Lucid Diagnostics (LUCD) Free Cash Flow (2020 - 2026)

Lucid Diagnostics has reported Free Cash Flow for 7 years, with the latest figure at -$12.3 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow rose 1.93% year-over-year to -$12.3 million; the trailing twelve-month figure through Mar 2026 stood at -$46.5 million (down 4.76% YoY), and the FY2025 full-year result was -$46.7 million, down 5.09% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$12.3 million, up from -$12.6 million in the prior quarter.
• The five-year high for Free Cash Flow was -$4.5 million in Q4 2022, with the low at -$15.4 million in Q2 2022.
• Historically, Free Cash Flow has averaged -$9.8 million across 5 years, with a median of -$10.2 million in 2024.
• The largest YoY upside for Free Cash Flow was 58.31% in 2022 against a maximum downside of 569.15% in 2022.
• Lucid Diagnostics' Free Cash Flow stood at -$4.5 million in 2022, then plunged by 127.62% to -$10.2 million in 2023, then rose by 0.24% to -$10.1 million in 2024, then fell by 24.82% to -$12.6 million in 2025, then climbed by 2.59% to -$12.3 million in 2026.
• The last three Free Cash Flow figures came in at -$12.3 million (Q1 2026), -$12.6 million (Q4 2025), and -$10.9 million (Q3 2025), per Business Quant data.